Eupraxia Pharmaceuticals (EPRX) Cash & Current Investments (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) reported Cash & Current Investments of $133.66 million for the quarter ended Jun 30, 2026, up 576.2% from $19.77 million a year earlier but down 3.8% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Cash & Current Investments (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals posted Cash & Current Investments of $80.56 million, up 143.4% from the prior year.
- Cash & Current Investments has increased for three consecutive years, with a three-year compound annual growth rate of 64.0% (years ended Dec 2022 to Dec 2025).
- By year, Cash & Current Investments came in at $33.1 million in the year ended Dec 31, 2024 (+71.1%), $19.34 million in the year ended Dec 31, 2023 (+5.9%) and $18.26 million in the year ended Dec 31, 2022.
- Five-year quarterly Cash & Current Investments spans a low of $8.66 million in the quarter ended Sep 30, 2024 and a high of $138.88 million in the quarter ended Mar 31, 2026.
- Year over year, Cash & Current Investments has now increased in each of the last four quarters, with growth averaging 297.8% over the last seven quarters.
- The high point for year-over-year Cash & Current Investments in five years was the quarter ended Sep 30, 2025 (growth of 927.0%); the low point was the quarter ended Mar 31, 2025 (a decline of 23.5%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $138.88 million (quarter ended Mar 31, 2026), $80.56 million (quarter ended Dec 31, 2025) and $88.96 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Eupraxia Pharmaceuticals | 276.70 Mn | -165.37 Mn | - | 133.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133.66 Mn |
| Mar 31, 2026 | 138.88 Mn |
| Dec 31, 2025 | 80.56 Mn |
| Sep 30, 2025 | 88.96 Mn |
| Jun 30, 2025 | 19.77 Mn |
| Mar 31, 2025 | 27.45 Mn |
| Dec 31, 2024 | 33.10 Mn |
| Sep 30, 2024 | 8.66 Mn |
| Jun 30, 2024 | 23.32 Mn |
| Mar 31, 2024 | 35.91 Mn |
| Dec 31, 2023 | 19.34 Mn |
| Dec 31, 2022 | 18.26 Mn |
API Access
Eupraxia Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();